Industry reports
Editor highlights

Publication dates

data types

Estrogen Market and Forecasts, April 2014

You might be interested in: breast cancer, drug, cancer, more »

1-10 of about 200 reports for Estrogen

Estrogen Business in The United States and Canada

  • Industry report
  • January 2012
  • 12 pages
  • by Corporation

... Source of estrogen production but estrogen can only be produced if the fetus or the mother supplies dehydroepiandrosterone (dhea), the estrogen prohormone. Studies show that the fetal zone of the fetal ...

The Brazilian Hormone Industry Brief

  • Industry report
  • May 2012
  • 6 pages

... Shows that the estrogen e2 is highly responsible for estrogenic activity in effluents at stps [14], and it is found in soil and water springs in some countries [14,15] which are mostly used as source ...

Drug and Medication Sector Analysis in The United States

  • Industry report
  • May 2012
  • 69 pages
  • by Research Paper

... Adjustments Changes in over 30 different hormones have been detected in pregnancy estrogens: increase significantly in pregnancy, influence carbohydrate, lipid, and bone metabolism Progesterone: relaxes ...

U.S. Breast Cancer Industry Analysis

  • Industry report
  • November 2012
  • 68 pages

... In breast cancer claim over exposure to chemical des between 1940 and 1971, many pregnant women were treated with a synthetic estrogen, diethylstilbestrol -- commonly known as des -- to prevent miscarriage ...

Hormone Sector in Europe

  • Industry report
  • July 2012
  • 27 pages

... To steroid and hormone research with a special section for only estrogens Analytical r&d o developing, standardizing and validating analytical methods o conducting stability studies of apis 19 ...

Pharmaceutical Market in The United States

  • Industry report
  • October 2012
  • 34 pages

... But increase risk for stroke, thromboembolic events, gallbladder disease, and urinary incontinence. estrogen plus progestin also increases risk for breast cancer and probable dementia, whereas estrogen alone ...

Pharmaceutical Sector Analysis

  • Industry report
  • June 2012
  • 107 pages

... Of hormones are important factors to consider when prescribing hormone therapy Overall use of a transdermal estrogen and micronized progesterone appear to be safest and most beneficial Consider ...

Breast Cancer Market Analysis (breast cancer, colorectal cancer, osteoporosis) in The United States

  • Industry report
  • May 2012
  • 57 pages

... Androstendione (androgen) to estrone in adrenals testosterone/androgens to estrogens in fat tissue Most women report no symptoms (or, mostly vaginal dryness) Some women continue to have hot flashes ...

Breast Cancer Business Analysis (breast cancer, stroke, colorectal cancer)

  • Industry report
  • April 2013
  • 110 pages

... Reduction was noted. As the age of users increased, this apparent protection against fatal chd attenuated. Results were similar with use of estrogen-alone or combination estrogen- progestin ht. Et ...

Breast Cancer Business

  • Industry report
  • November 2013
  • 19 pages

... Bilateral oophorectomy before the age of 40 reduces lifetime risk by 50 percent [112] ; yet, this risk reduction is eliminated if replacement estrogens are given.Older at menopause, which is comparable ...

» Purchase Premium Reports (From $ 495 - $ 9 995)

27 reports for Estrogen
Premarin (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022

Premarin (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • July 2013
  • by Global Data

Premarin (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade, it ...

» Read our Company Profiles

1 Companies for Estrogen

Roche Holding AG


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.